CIVIL ENGINEERING 365 ALL ABOUT CIVIL ENGINEERING


  • 1.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article 

    Google Scholar
     

  • 2.

    Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US Women, 2000–2012. JAMA. 2018;319:154–64.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2015;24:1495–506.

    PubMed 

    Google Scholar
     

  • 4.

    Gulati M, Mulvagh SL. The connection between the breast and heart in a woman: breast cancer and cardiovascular disease. Clin Cardiol. 2018;41:253–7.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Abdel-Qadir H, Austin PC, Lee DS, Amir E, Tu JV, Thavendiranathan P, et al. A population-based study of cardiovascular mortality following early-stage breast cancer. JAMA Cardiol. 2017;2:88–93.

    PubMed 

    Google Scholar
     

  • 6.

    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–7.

    CAS 
    PubMed 

    Google Scholar
     

  • 7.

    Schwartz AM, Henson DE, Chen D, Rajamarthandan S. Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161708 cases of breast cancer from the SEER Program. Arch Pathol Lab Med. 2014;138:1048–52.


    Google Scholar
     

  • 8.

    Solak M, Turkoz FP, Keskin O, Aksoy S, Babacan T, Sarici F, et al. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality. J BUON. 2015;20:737–45.

    PubMed 

    Google Scholar
     

  • 9.

    Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, et al. Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 1995;76:268–74.

    CAS 
    PubMed 

    Google Scholar
     

  • 10.

    Adami HO, Malker B, Meirik O, Persson I, Bergkvist L, Stone B. Age as a prognostic factor in breast cancer. Cancer. 1985;56:898–902.

    CAS 
    PubMed 

    Google Scholar
     

  • 11.

    Arce-Salinas C, Aguilar-Ponce JL, Villarreal-Garza C, Lara-Medina FU, Olvera-Caraza D, Alvarado Miranda A, et al. Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients. Breast Cancer Res Treat. 2014;146:183–8.

    CAS 
    PubMed 

    Google Scholar
     

  • 12.

    Lafourcade A, His M, Baglietto L, Boutron-Ruault MC, Dossus L, Rondeau V. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort. BMC Cancer. 2018;18:171–80.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 13.

    Alburo AF, Dubon E, Aguirre I, Pérez V, Hernandez-Rodriguez NA. Estrogen receptor β expression in high-grade breast cancer patients may predict metastases and mortality. J Clin Oncol. 2005;23:671.


    Google Scholar
     

  • 14.

    Caruso R, Nanni M, Riba M, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry. 2017;29:1–14.


    Google Scholar
     

  • 15.

    Hodgkinson K, Butow P, Hunt G, Pendlebury S, Hobbs K, Wain G. Breast cancer survivors’ supportive care needs 2–10 years after diagnosis. Support Care Cancer. 2007;15:515–23.

    PubMed 

    Google Scholar
     

  • 16.

    Balouchi A, Hashemi S-M, Rafiemanesh H, Amirshahi M, Afsargharehbagh R. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;176:519–33.

    PubMed 

    Google Scholar
     

  • 17.

    Hashemi S-M, Rafiemanesh H, Aghamohammadi T, Badakhsh M, Amirshahi M, Sari M, et al. Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2019;27:166–78.

    PubMed 

    Google Scholar
     

  • 18.

    Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatrics Soc. 2004;52:106–11.


    Google Scholar
     

  • 19.

    Vodermaier A, Linden W, Rnic K, Young SN, Ng A, Ditsch N, et al. Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer. Breast Cancer Res Treat. 2014;143:373–84.

    CAS 
    PubMed 

    Google Scholar
     

  • 20.

    Kanani R, Davies EA, Hanchett N, Jack RH. The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England. Psycho-oncology. 2016;25:19–27.

    PubMed 

    Google Scholar
     

  • 21.

    Iglay K, Santorelli ML, Hirshfield KM, Williams JM, Rhoads GG, Lin Y, et al. Impact of preexisting mental illness on all-cause and breast cancer-specific mortality in elderly patients with breast cancer. J Clin Oncol. 2017;35:4012–8.

    PubMed 

    Google Scholar
     

  • 22.

    Liang X, Margolis KL, Hendryx M, Reeves K, Wassertheil-Smoller S, Weitlauf J, et al. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017;123:3107–15.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 23.

    Desai R, Camacho F, Tan X, LeBaron V, Blackhall L, Balkrishnan R. Mental health comorbidities and elevated risk of opioid use in elderly breast cancer survivors using adjuvant endocrine treatments. J Oncol Pract. 2019;15:e777–86.

    PubMed 

    Google Scholar
     

  • 24.

    Shim EJ, Lee JW, Cho J, Jung HK, Kim NH, Lee JE, et al. Association of depression and anxiety disorder with the risk of mortality in breast cancer: a National Health Insurance Service study in Korea. Breast Cancer Res Treat. 2019;179. https://doi.org/10.1007/s10549-10019-05479-10543.

  • 25.

    Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer. 2005;41:1710–4.

    CAS 
    PubMed 

    Google Scholar
     

  • 26.

    Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28:396–402.

    PubMed 

    Google Scholar
     

  • 27.

    Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105:209–19.

    PubMed 

    Google Scholar
     

  • 28.

    Phillips KA, Osborne RH, Giles GG, Dite GS, Apicella C, Hopper JL, et al. Psychosocial factors and survival of young women with breast cancer: A population-based prospective cohort study. J Clin Oncol. 2008;26:4666–71.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Chen S, Chang C, Chen K, Liu C. Association between depressive disorders and risk of breast cancer recurrence after curative surgery. Medicine. 2016;95:1–6.


    Google Scholar
     

  • 30.

    Eskelinen M, Korhonen R, Selander T, Ollonen P. Beck depression inventory as a predictor of long-term outcome among patients admitted to the breast cancer diagnosis unit: a 25-year cohort study in Finland. Anticancer Res. 2017;37:819–24.

    PubMed 

    Google Scholar
     

  • 31.

    Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40:1797–810.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 32.

    Satin JR, Wolfgang L, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349–61.

    PubMed 

    Google Scholar
     

  • 33.

    Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29:413–420.

    PubMed 

    Google Scholar
     

  • 34.

    Mirosevic S, Jo B, Kraemer HC, Ershadi M, Neri E, Spiegel D. “Not just another meta-analysis”: sources of heterogeneity in psychosocial treatment effect on cancer survival. Cancer Med. 2019;8:363–73.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 35.

    Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psycho-oncology. 2010;16:277–86.


    Google Scholar
     

  • 36.

    Bredal IS, Sandvik L, Karesen R, Ekeberg O. Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study. Psycho-oncology. 2011;20:1102–7.

    PubMed 

    Google Scholar
     

  • 37.

    Chen H, Liu D, Guo L, Cheng X, Guo N, Shi M. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling: chronic psychological stress promotes lung metastatic colonization. J Pathol. 2017;244:49–60.

    PubMed 

    Google Scholar
     

  • 38.

    Qin JF, Jin FJ, Li N, Guan HT, Lan L, Ni H, et al. Adrenergic receptor beta2 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment. BMB Rep. 2015;48:295–300.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 39.

    Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939–44.

    CAS 
    PubMed 

    Google Scholar
     

  • 40.

    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–12.

    CAS 
    PubMed 

    Google Scholar
     

  • 41.

    Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

    PubMed 

    Google Scholar
     

  • 42.

    Higgins JPT, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 43.

    Egger M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;316:469–77.


    Google Scholar
     

  • 44.

    Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, et al. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2019;5:12–20.

    PubMed 

    Google Scholar
     

  • 45.

    Graham J, Ramirez A, Love S, Richards M, Burgess C. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. Bmj. 2002;324:1420–2.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 46.

    Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jørgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics. 2003;44:24–30.

    PubMed 

    Google Scholar
     

  • 47.

    Batty GD, Russ TC, Stamatakis E, Kivimaki M. Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017;356:1–11.


    Google Scholar
     

  • 48.

    Strine TW, Mokdad AH, Dube SR, Balluz LS, Gonzalez O, Berry JT, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry. 2008;30:127–37.

    PubMed 

    Google Scholar
     

  • 49.

    Souza BFD, Moraes JAD, Inocenti A, Santos MAND, Silva AEBDC, Miasso AI. Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence. Rev Lat Am Enfermagem. 2014;22:866–73.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 50.

    Kim JM, Jang J-E, Stewart R, Kim S-Y, Kim S-W, Kang H-J, et al. Determinants of suicidal ideation in patients with breast cancer. Psycho-oncology. 2013;22:2848–56.

    PubMed 

    Google Scholar
     

  • 51.

    Pruessner M, Hellhammer DH, Pruessner JC, Lupien SJ. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom Med. 2003;65:92–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 52.

    Sephton S, Sapolsky R, Kraemer H, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000.

    CAS 
    PubMed 

    Google Scholar
     

  • 53.

    Cui B, Luo Y, Tian P, Peng F, Lu J, Yang Y, et al. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. J Clin Investig. 2019;129:1030–46.

    PubMed 

    Google Scholar
     

  • 54.

    Kamiya A, Hayama Y, Kato S, Shimomura A, Shimomura T, Irie K, et al. Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression. Nat Neurosci. 2019;22:1289–305.

    CAS 
    PubMed 

    Google Scholar
     

  • 55.

    Haomin Yang JSB, Fang Fang, Chiesa Flaminia, Johansson AnnaLV, Hall Per, Czene Kamila. Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer. Int J Cancer. 2016;140:841–52.

    PubMed 

    Google Scholar
     

  • 56.

    Fischer D, Wedel B. Anxiety and depression disorders in cancer patients: incidence, diagnosis and therapy. Mag Eur Med Oncol. 2012;5:52–4.


    Google Scholar
     

  • 57.

    Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011;33:203–16.

    PubMed 

    Google Scholar
     

  • 58.

    Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet. 1999;354:1331–6.

    CAS 
    PubMed 

    Google Scholar
     

  • 59.

    Lovibond PF. Long-term stability of depression, anxiety, and stress syndromes. J Abnorm Psychol. 1998;107:520–6.

    CAS 
    PubMed 

    Google Scholar
     

  • 60.

    Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.

    PubMed 

    Google Scholar
     

  • 61.

    Liliana Coutiño-Escamilla, Maricela Piña-Pozas, Aurelio Tobías, et al. Non-pharmacological therapies for depressive symptoms in breast cancer patients: Systematic review and meta-analysis of randomized clinical trials. Breast. 2019;44:135–43.


    Google Scholar
     

  • 62.

    Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011;20:131–7.

    PubMed 

    Google Scholar
     

  • 63.

    Busby J, Mills K, Zhang SD, Liberante FG, Cardwell CR. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study. Breast Cancer Res BCR. 2018;20:4–13.

    PubMed 

    Google Scholar
     

  • 64.

    Baker Holly. Use of antidepressants and breast cancer recurrence. Lancet Oncol. 2016;17:e11.

    PubMed 

    Google Scholar
     

  • 65.

    Chubak J, Buist DSM, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat. 2008;112:123–32.

    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *